| RS753467517 |
FARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS753470112 |
GRK1
|
Health Risk |
Likely pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS753470655 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS753471215 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS753471298 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS753471483 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS753472316 |
NPR2
|
Health Risk |
Pathogenic |
Short stature with nonspecific skeletal abnormalities, Acromesomelic dysplasia 1 |
| RS753472891 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS753472937 |
CARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 27, Combined oxidative phosphorylation defect type 27 |
| RS753473749 |
SIX3
|
Health Risk |
Pathogenic |
Holoprosencephaly 2, Holoprosencephaly 2 |
| RS753473819 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS753474547 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
LZTR1-related schwannomatosis, Cardiovascular phenotype |
| RS753474870 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS753475025 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS753475114 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS753475896 |
CNOT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with speech delay, autism |
| RS753476209 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS753476926 |
TLR6
|
Health Risk |
risk factor |
Multisystem inflammatory syndrome in children, Multisystem inflammatory syndrome in children |
| RS753477704 |
KIF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Neuroblastoma |
| RS753479021 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS753480088 |
WDPCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, WDPCP-related disorder |
| RS753480401 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS753483823 |
GUSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Mucopolysaccharidosis type 7 |
| RS75348431 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS753485021 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS753485145 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS753485165 |
SLC45A2
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 4, SKIN/HAIR/EYE PIGMENTATION 5 |
| RS753486471 |
SMAD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS753488664 |
GUCY2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 1, Cone-rod dystrophy 6 |
| RS753488821 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS753488873 |
MSTO1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome, Inborn mitochondrial myopathy |
| RS753489572 |
COQ6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS753490759 |
VARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS753491072 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Birt-Hogg-Dube syndrome |
| RS753491527 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 5, Inborn genetic diseases |
| RS753492211 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS753492974 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS753493990 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hearing loss, autosomal recessive |
| RS753494538 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS753495484 |
NHEJ1
|
Health Risk |
Likely pathogenic |
Cernunnos-XLF deficiency, Cernunnos-XLF deficiency |
| RS753496711 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Cardiovascular phenotype |
| RS753496815 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS753497329 |
PGAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS753497692 |
PLOD2
|
Health Risk |
Likely pathogenic |
— |
| RS753498008 |
OFD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Orofaciodigital syndrome I, Joubert syndrome |
| RS753498044 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS753498326 |
LTBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachyolmia-amelogenesis imperfecta syndrome, LTBP3-related disorder |
| RS753499012 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS753500354 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Rubinstein-Taybi syndrome |
| RS753500924 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Encephalopathy due to GLUT1 deficiency, Dystonia 9 |
| RS753501228 |
HOXB13
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Prostate cancer |
| RS753503405 |
MAN1B1
|
Health Risk |
Pathogenic |
Rafiq syndrome, MAN1B1-related disorder |
| RS753503617 |
PSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1V, Alzheimer disease 4 |
| RS753503972 |
LMF1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS753503984 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Inborn genetic diseases |
| RS753505066 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS753505082 |
EGLN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Erythrocytosis, familial |
| RS753505084 |
ERCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 2, Cerebrooculofacioskeletal syndrome 2 |
| RS753505203 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS753505333 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS753506183 |
XPC
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum, group C |
| RS753506843 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS753507995 |
EIF2B5
|
Health Risk |
Pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS753508874 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type A |
| RS753509616 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS753509905 |
TPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS753511073 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS753512282 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS753512677 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS753512842 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS753514580 |
TRDN
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 5, Catecholaminergic polymorphic ventricular tachycardia 5 |
| RS753515010 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1 |
| RS753517219 |
NPHP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Joubert syndrome with renal defect |
| RS753517348 |
SYN1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 50 |
| RS753517944 |
TULP1
|
Health Risk |
Pathogenic |
— |
| RS753518915 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS753519057 |
LRRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS753519199 |
MSH5
|
Health Risk |
Likely pathogenic |
Non-obstructive azoospermia, Spermatogenic failure 74 |
| RS753520553 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS753520867 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, FGFR3-related disorder |
| RS75352090 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Combined immunodeficiency due to DOCK8 deficiency |
| RS753521037 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized juvenile polyposis/juvenile polyposis coli, Hereditary cancer-predisposing syndrome |
| RS753521391 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS753522100 |
TMEM106B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS753522380 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS753523115 |
SLC12A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS753523567 |
PEX19
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 12A (Zellweger), Peroxisome biogenesis disorder 12A (Zellweger) |
| RS753524038 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS753526743 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS753527196 |
XPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group C |
| RS753527304 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS753527390 |
RFT1
|
Health Risk |
Conflicting classifications of pathogenicity |
RFT1-congenital disorder of glycosylation, RFT1-congenital disorder of glycosylation |
| RS753527559 |
DUOX2
|
Health Risk |
Likely pathogenic |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS753528166 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS753528227 |
NR1H4
|
Health Risk |
Likely pathogenic |
— |
| RS753528947 |
D2HGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
D-2-hydroxyglutaric aciduria 1, D-2-hydroxyglutaric aciduria 1 |
| RS753529210 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS753529923 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS753529924 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS753530916 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |